Contents

Current Drug Discovery Technologies, Volume 9 - Number 2

Editorial [Hot Topic: New Anticoagulant Drugs: A Change of Paradigm? (Guest Editor: Antonio Gomez-Outes)]

, 9(2): 81 - 82

Antonio Gomez-Outes


DOI: 10.2174/1570163811209020081




Discovery of Anticoagulant Drugs: A Historical Perspective

, 9(2): 83 - 104

Antonio Gomez-Outes, M Luisa Suarez-Gea, Gonzalo Calvo-Rojas, Ramon Lecumberri, Eduardo Rocha, Carmen Pozo-Hernandez, Ana Isabel Terleira-Fernandez and Emilio Vargas-Castrillon


DOI: 10.2174/1570163811209020083




Clinical Drug Development in Thromboembolic Diseases: Regulatory and Methodological Approach

, 9(2): 105 - 118

Gonzalo Calvo-Rojas and Antonio Gomez-Outes


DOI: 10.2174/1570163811209020105




New Oral Anticoagulants for Venous Thromboembolism: Focus on Factor Xa and Thrombin Inhibitors

, 9(2): 119 - 128

Cecilia Becattini, Alessandra Lignani and Giancarlo Agnelli


DOI: 10.2174/1570163811209020119




New Parenteral Anticoagulants: Focus on Factor Xa and Thrombin Inhibitors

, 9(2): 129 - 136

Ingo Ahrens and Christoph Bode


DOI: 10.2174/1570163811209020129




Regulatory Considerations for Generic or Biosimilar Low Molecular Weight Heparins

, 9(2): 137 - 142

Alfredo Garcia-Arieta and Antonio Blazquez


DOI: 10.2174/1570163811209020137




Reversing Anticoagulant Therapy

, 9(2): 143 - 149

Shari Ghanny, Theodore E. Warkentin and Mark A. Crowther


DOI: 10.2174/1570163811209020143




New Targets for Anticoagulation and Future Perspectives

, 9(2): 150 - 155

Jack Ansell and David Askin


DOI: 10.2174/1570163811209020150




Webmaster Contact: info@benthamscience.org
Copyright © 2018 Bentham Science